Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity

The present invention relates to crystalline form A of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)-benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), a method for preparing the crystalline form A, and the use thereof.

Saved in:
Bibliographic Details
Main Authors Zhao, Rui, Ding, Zhaozhong, Wang, Zheng, Yang, Ling, Hu, Yinghu, Zhou, Yilong, Sun, Fei
Format Patent
LanguageEnglish
Published 16.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to crystalline form A of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)-benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), a method for preparing the crystalline form A, and the use thereof.
Bibliography:Application Number: US201916582575